Relaxera is supporting and attending the 10th International Conference on Relaxin Family Peptides in Health and Disease.
While celebrating 100 years of Relaxin discovery featured presenters cover all aspects of basic biology, evolution, physiology, and as well pharmacology with the potential clinical applications of relaxin and related peptides. Novel applications in diagnostics and therapeutics are discussed.
Thomas Bernd Dschietzig presents the unique properties of full-length synthetic human relaxin-2 to tackle HFpEF pandemic and provides data from animal models and human HFpEF myocardium.
From the 2nd – 6th August 2026 the University of Nottingham is hosting this conference with 16 scientific sessions in 5 days.